Estimating the impact of cefuroxime versus cefazolin and amoxicillin/clavulanate use on future collateral resistance: a retrospective comparison.

Michal ChowersTamir ZehaviBat Sheva GottesmanAvi BarazDaniel NevoLilach Hadany

Published in: The Journal of antimicrobial chemotherapy (2022)

Our results indicate that treatment with amoxicillin/clavulanate or cefazolin is preferable to cefuroxime, in terms of future collateral resistance. The results presented here are a first step towards quantitative estimations of the ecological damage caused by different antibiotics.

Keyphrases

current status
oxidative stress
climate change
human health
risk assessment
combination therapy
mass spectrometry
replacement therapy
smoking cessation